ERBB2 and neoplasm: The major findings are that ALCAM expression at the critically important intercellular junctions of primary breast cancer tumors is markedly lower in AA women compared to CAU women, regardless of age, histological grade, tumor size and lymph node involvement, ER/PR and HER2-neu status.